Abstract

The concept of immunization was started in Japan in 1849 when Jenner’s cowpox vaccine seed was introduced, and the current immunization law was stipulated in 1948. There have been two turning points for amendments to the immunization law: the compensation remedy for vaccine-associated adverse events in 1976, and the concept of private vaccination in 1994. In 1992, the regional Court of Tokyo, not the Supreme Court, decided the governmental responsibility on vaccine-associated adverse events, which caused the stagnation of vaccine development. In 2010, many universal vaccines became available as the recommended vaccines, but several vaccines, including mumps, zoster, hepatitis B, and rota vaccines, are still voluntary vaccines, not universal routine applications. In this report, immunization strategies and vaccine development are reviewed for each vaccine item and future vaccine concerns are discussed.

Highlights

  • Introduction ofHib, PCV7, and human papilloma virus vaccines (HPV)Hib and PCV are the major pathogens of bacterial meningitis and invasive systemic bacteremia, and they cause serious pneumonia

  • Hepatitis B virus vaccine Haemophilus influenzae type b conjugated with tetanus toxoid Human papilloma virus vaccine Japanese encephalitis vaccine Inactivated polio vaccine Loop-mediated isothermal amplification Measles, mumps, and rubella-combined vaccine Measles and rubella-combined vaccine Neuraminidase Neutralization test Live oral polio vaccine 7-valent Streptococcus pneumoniae conjugated vaccine with recombinant diphtheria toxoid Pertussis toxin Tetanus toxoid combined with a reduced concentration of diphtheria toxoid and acellular pertussis Vaccine-associated paralytic polio Varicella zoster virus vaccine

  • Routine recommended vaccines consist of BCG, acellular pertussis vaccine (DTaP), measles and rubella combined vaccine (MR), inactivated polio (IPV), Hib, PCV7, HPV, and Japanese encephalitis vaccine (JEV)

Read more

Summary

VAP VZV

Hepatitis B virus vaccine Haemophilus influenzae type b conjugated with tetanus toxoid Human papilloma virus vaccine Japanese encephalitis vaccine Inactivated polio vaccine Loop-mediated isothermal amplification Measles, mumps, and rubella-combined vaccine Measles and rubella-combined vaccine Neuraminidase Neutralization test Live oral polio vaccine 7-valent Streptococcus pneumoniae conjugated vaccine with recombinant diphtheria toxoid Pertussis toxin Tetanus toxoid combined with a reduced concentration of diphtheria toxoid and acellular pertussis Vaccine-associated paralytic polio Varicella zoster virus vaccine

Dawn of vaccines in Japan
Immunization law and schedule
Measles and rubella elimination
Is the DTaP vaccine effective in controlling pertussis?
Does the influenza split vaccine prevent infection?
Findings
Requirement for future immunization
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call